Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
72.1M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
13.6M
-
Shares change
-
-1.85M
-
Total reported value, excl. options
-
$40.5M
-
Value change
-
-$7.1M
-
Number of buys
-
25
-
Number of sells
-
-31
-
Price
-
$2.98
Significant Holders of Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) as of Q1 2020
66 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share as of Q1 2020.
Ovid Therapeutics Inc. - Common Stock, par value $0.001 per share (OVID) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.6M shares
of 72.1M outstanding shares and own 18.88% of the company stock.
Largest 10 shareholders include Consonance Capital Management LP (2.58M shares), FMR LLC (2.08M shares), BVF INC/IL (1.29M shares), RENAISSANCE TECHNOLOGIES LLC (853K shares), CHI Advisors LLC (828K shares), AXA (816K shares), BlackRock Inc. (490K shares), MILLENNIUM MANAGEMENT LLC (399K shares), PLATINUM INVESTMENT MANAGEMENT LTD (383K shares), and Ikarian Capital, LLC (378K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.